Citadel Advisors’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,000
Closed -$15.2K 13599
2025
Q3
$15.2K Sell
17,000
-10,900
-39% -$15.9K ﹤0.01% 12532
2025
Q2
$60.3K Sell
27,900
-24,900
-47% -$90.2K ﹤0.01% 11676
2025
Q1
$254K Buy
52,800
+41,300
+359% +$235K ﹤0.01% 9959
2024
Q4
$74.1K Buy
11,500
+10,500
+1,050% +$51.1K ﹤0.01% 11884
2024
Q3
$4.01K Buy
1,000
+600
+150% +$2.48K ﹤0.01% 13603
2024
Q2
$1.28K Buy
+400
New +$1.36K ﹤0.01% 13841

Other funds holding MYO

Citadel Advisors's MYO Position: Q3 2025 in Review

Citadel Advisors sold out of Myomo (MYO) in Q3 2025, closing a stake of 324,590 shares — an estimated $472K sold.

Citadel Advisors first reported a position in MYO in Q3 2017 and held it in 15 quarters. The position peaked at $1.27M in Q1 2025. 66 funds tracked by Wall St. Rank hold MYO as of Q3 2025.

  • Citadel Advisors reported no remaining Myomo position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 324,590 Myomo shares in Q3 2025, an estimated $472K.
  • Citadel Advisors first reported a position in Myomo in Q3 2017 and held it in 15 quarters.
  • Citadel Advisors's Myomo position peaked at $1.27M in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Myomo as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.